Pilot RCT of Therapeutic Hypothermia Plus Neuromuscular Blockade in COVID-19 Patients With ARDS

Stopped Competition from other studies and initiation of a larger multi center trial

Conditions

• Respiratory Distress Syndrome, Adult
• Sars-CoV2

Interventions

• DEVICE: Hypothermia
• DRUG: Neuromuscular Blocking Agents
• DEVICE: Standard of Care

Sponsor

University of Maryland, Baltimore